Staphylococcus Aureus Skin and Soft Tissue Infections

This study is currently recruiting participants.

Verified March 2012 by Medical Corps, Israel Defense Force

Sponsor:

Information provided by (Responsible Party):

Medical Corps, Israel Defense Force

ClinicalTrials.gov Identifier:

NCT01385514

First received: June 28, 2011

Last updated: March 22, 2012

Last verified: March 2012

History of Changes

Tracking Information

First Received Date ^ICMJE

June 28, 2011

Last Updated Date

March 22, 2012

Start Date ^ICMJE

July 2011

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT01385514 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Staphylococcus Aureus Skin and Soft Tissue Infections

Official Title ^ICMJE

Evaluating Strategies to Prevent Staphylococcus Aureus Skin and Soft Tissue Infections in Soldiers During Infantry Training

Brief Summary

The purpose of this study is to evaluate strategies to prevent Staphylococcus aureus skin and soft tissue infections in soldiers during infantry training.

This study will be conducted on three different bases among groups of male recruits to IDF training base. They will provide nasal swabs to detect Staphylococcus aureus carriage in two time points: 1. before mixing and training in confined settings, reflecting carriage acquired before entering 2. After 14-30 days. All soldiers will be under surveillance for skin infection until the end of the training program.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Cohort
Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Retention: Samples Without DNA

Description:

nasal swabs to detect Staphylococcus aureus skin infection to detect Staphylococcus aureus

Sampling Method

Non-Probability Sample

Study Population

the population of the study will be selected from infantry training bases in the IDF

Condition ^ICMJE

Staphylococcus Aureus

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

company A-Training Base No.1
company A-Training Base No.2
company A-Training Base No.3

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

1050

Estimated Completion Date

December 2013

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

new recruit for a combat training unit

Gender

Male

Ages

18 Years to 25 Years

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact: Michael Hartal, MD

+972-3-7374137

Mhuerta2@gmail.com

Location Countries ^ICMJE

Israel

Administrative Information

NCT Number ^ICMJE

NCT01385514

Other Study ID Numbers ^ICMJE

1042-2011

Has Data Monitoring Committee

Responsible Party

Medical Corps, Israel Defense Force

Study Sponsor ^ICMJE

Medical Corps, Israel Defense Force

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Michael Hartal, MD

IDF

Information Provided By

Medical Corps, Israel Defense Force

Verification Date

March 2012

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top